PHRRF (PharmaTher Holdings) EBIT per Share : $-0.02 (TTM As of Aug. 2024)

View and export this data going back to 2020. Start your Free Trial

What is PharmaTher Holdings EBIT per Share?

PharmaTher Holdings's EBIT per Share for the three months ended in Aug. 2024 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Aug. 2024 was $-0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for PharmaTher Holdings's EBIT per Share or its related term are showing as below:

PHRRF's 3-Year EBIT Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.8
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

PharmaTher Holdings's EBIT for the three months ended in Aug. 2024 was $-0.24 Mil.

PharmaTher Holdings EBIT per Share Historical Data

The historical data trend for PharmaTher Holdings's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings EBIT per Share Chart

PharmaTher Holdings Annual Data

Trend

May21

May22

May23

EBIT per Share

-0.03

-0.04

-0.03

PharmaTher Holdings Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	Aug24
EBIT per Share	Get a 7-Day Free Trial											-0.01	-0.01	-0.01	-	-

PharmaTher Holdings EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

PharmaTher Holdings's EBIT per Share for the fiscal year that ended in May. 2023 is calculated as

	EBIT per Share		(A: May. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-2.97	/	88.169
=	-0.03

PharmaTher Holdings's EBIT per Share for the quarter that ended in Aug. 2024 is calculated as

	EBIT per Share		(Q: Aug. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.241	/	88.519
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02

PharmaTher Holdings (OTCPK:PHRRF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

PharmaTher Holdings EBIT per Share Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaTher Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (OTCPK:PHRRF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

PHRM:Canada

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmather.com

PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.